2-(2-Methyl-1,3-thiazol-4-yl)morpholine → HCID 53770609, compound

HRID 1451429Notes

Reaction equation

HRID 1451429 reaction equation
[CH3:1][C:2]1[S:3][CH:4]=[C:5]([CH:7]2[O:12][CH2:11][CH2:10][NH:9][CH2:8]2)[N:6]=1.[C:13]([CH:17]=[C:18]([C:20]1[CH:25]=[CH:24][C:23]([CH2:26][C:27](=O)[CH3:28])=[CH:22][CH:21]=1)[CH3:19])([O:15][CH3:16])=[O:14]>>[C:13]([CH:17]=[C:18]([C:20]1[CH:25]=[CH:24][C:23]([CH2:26][CH:27]([N:9]2[CH2:10][CH2:11][O:12][CH:7]([C:5]3[N:6]=[C:2]([CH3:1])[S:3][CH:4]=3)[CH2:8]2)[CH3:28])=[CH:22][CH:21]=1)[CH3:19])([O:15][CH3:16])=[O:14]

Participants

3

Procedure

Prepared analogously to Example 13 by reaction of 2-(2-methyl-thiazol-4-yl)morpholine with 1-[4-(2-carbomethoxy-1-methyl-ethenyl)phenyl]propan-2-one followed by purification of the base on a silica gel column using chloroform/methanol/ammonia=9:1:0.1 as eluant.

Workup

  1. customfollowed by purification of the base on a silica gel column

Sources & evidence

ORD record
ord-b73c9eb6336f4bc693fd91106d428cb2
Source dataset
uspto-grants-1997_02
Patent number
US05604225

Reaction notes

Loading…